HI TOPK 032
Cat. No. 4555
Chemical Name: N-(12-Cyanoindolizino[2,3-b]quinoxa
Biological ActivityT-LAK-cell-originated protein kinase (TOPK) inhibitor; exhibits selectivity for TOPK over other MAPKK family members including ERK1, JNK1 and p38. Blocks proliferation of HCT116 colon cancer cells; suppresses tumor growth in a colon cancer xenograft model. Also inhibits Chk1 (IC50 = 9.6 μM).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Kim et al (2012) Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res. 72 3060. PMID: 22523035.
Li et al (2011) Discovery of novel checkpoint kinase 1 inhibitors by virtual screening based on multiple crystal structures. J.Chem.Inf.Model. 51 2904. PMID: 21955044.
If you know of a relevant reference for HI TOPK 032 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses HI TOPK 032 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: HI TOPK 032, supplier, HITOPK032, TOPK, T-LAK-cell-originated, protein, kinase, MAPKK, inhibitors, inhibits, selective, antitumor, colon, cancer, cells, antiproliferatives, Tocris Bioscience, Other MAPK Inhibitor products
Find multiple products by catalog number
New Products in this Area
Selective p38α/β inhibitor; orally bioavailable
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.